Ieq Capital LLC Purchases Shares of 19,500 Chemed Corporation $CHE

Key Points

• Ieq Capital purchased 19,500 Chemed shares worth approximately $9.1 million, while institutional investors collectively own 95.85% of the company.
• Chemed exceeded quarterly earnings and revenue estimates, reporting EPS of $6.06 and revenue of $673.25 million, with revenue up 8.8% year over year. Analysts maintain a consensus “Hold” rating with an average price target of $530.75.
• The company raised its quarterly dividend from $0.60 to $0.70 per share, resulting in an annualized dividend of $2.80 and a yield of about 0.5%; meanwhile, insiders sold 3,537 shares during the last quarter.

Ieq Capital LLC purchased a new position in shares of Chemed Corporation (NYSE:CHE - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 19,500 shares of the company's stock, valued at approximately $9,082,000. Ieq Capital LLC owned about 0.15% of Chemed at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company's stock valued at $2,374,667,000 after purchasing an additional 5,549,876 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Chemed during the 2nd quarter worth about $691,290,000. JPMorgan Chase & Co. increased its position in Chemed by 4.4% during the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company's stock worth $223,301,000 after purchasing an additional 21,932 shares in the last quarter. AQR Capital Management LLC increased its position in Chemed by 89.2% during the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company's stock worth $139,302,000 after purchasing an additional 153,469 shares in the last quarter. Finally, TD Asset Management Inc raised its holdings in Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company's stock valued at $138,860,000 after buying an additional 22,715 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CHE. Bank of America reaffirmed a "neutral" rating on shares of Chemed in a research report on Wednesday, July 29th. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 1st. Oppenheimer increased their price target on Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a report on Friday, July 31st. Royal Bank Of Canada raised their price objective on Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. Finally, Zacks Research upgraded Chemed from a "strong sell" rating to a "hold" rating in a research note on Monday, April 27th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $530.75.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the transaction, the chief executive officer owned 70,418 shares in the company, valued at $37,991,215.18. The trade was a 2.76% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Patrick P. Grace sold 190 shares of the company's stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the transaction, the director directly owned 3,533 shares of the company's stock, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 3,537 shares of company stock valued at $1,782,654 in the last quarter. Company insiders own 3.33% of the company's stock.

Chemed Stock Up 0.1%

NYSE CHE opened at $541.33 on Monday. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $557.00. The business has a 50 day moving average price of $499.24 and a two-hundred day moving average price of $446.50. The stock has a market cap of $7.08 billion, a PE ratio of 27.19, a P/E/G ratio of 2.05 and a beta of 0.51.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million for the quarter, compared to analyst estimates of $665.04 million. During the same quarter last year, the firm posted $4.27 earnings per share. The business's quarterly revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, sell-side analysts predict that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be paid a dividend of $0.70 per share. This is a positive change from Chemed's previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a yield of 0.5%. Chemed's payout ratio is presently 14.06%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source